This PhD project is offered on a self-funding basis. It is open to applicants with funding or those applying to funding sources. Details of tuition fees can be found at View Website.
A bench fee is also payable on top of the tuition fee to cover specialist equipment or laboratory costs required for the research. Applicants should contact the primary supervisor for further information about the fee associated with the project.
i) Ruzic, D.; Petkovic, M.; Agbaba, D.; Ganesan, A.; Nikolic, K. Combined Ligand and Fragment‐based Drug Design of Selective Histone Deacetylase–6 Inhibitors. Mol. Informatics 2019, 38, 1800083
ii) Da Mota, S. R.; Bailey, S.; Strivens, R. A.; Hayden, A. L.; Douglas, L. R.; Duriez, P. J.; Borrello, M. T.; Benelkebir, H.; Ganesan, A.; Packham, G.; Crabb, S. J. LSD1 Inhibition Attenuates Androgen Receptor V7 Splice Variant Activation in Castration Resistant Prostate Cancer Models. Cancer Cell Int. 2018, 18, 71
iii) Lecointre, B.; Narozny, R.; Borrello, M. T.; Senger, J.; Chakrabarti, A.; Jung, M.; Marek, M.; Romier, C.; Melesina, J.; Sippl, W.; Bischoff, L.; Ganesan, A. Isoform-selective HDAC1/6/8 Inhibitors with an Imidazo-ketopiperazine Cap Containing Stereochemical Diversity. Phil. Trans. R. Soc. B 2018, 373, 20170364